Interleukin 1 β (IL-1B) and IL-1 antagonist receptor (IL-1RN) gene polymorphisms are associated with the genetic susceptibility and steroid dependence in patients with ulcerative colitis

Journal of Clinical Gastroenterology

Volumn 45, Issue 6, 2011, Pages 531-535

  Yamamoto Furusho, Jesús K ^a   Santiago Hernández, Jean J ^a   Pérez Hernández, Nonanzit ^b   Ramírez Fuentes, Silvestre ^b   Fragoso, José Manuel ^b   Vargas Alarcón, Gilberto ^b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

genetic susceptibility; IL 1 polymorphism; Mexican; ulcerative colitis

Indexed keywords

AZATHIOPRINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; STEROID;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE CLUSTER; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; AGED; COLITIS, ULCERATIVE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIANS, NORTH AMERICAN; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MALE; MEXICO; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 79958859708     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181faec51     Document Type: Article

References (33)

1. Satsangi J, Jewell DP, Bell JI. The genetics of inflammatory bowel disease. Gut. 1997;40:572-574. (Pubitemid 27278320)
2. Yamamoto-Furusho JK. Immunogenetics of chronic ulcerative colitis. Rev Invest Clin. 2003;55:705-710.
3. Rodriguez-Bores L, Fonseca GC, Villeda MA, et al. Novel genetic markers in inflammatory bowel disease. World J Gastroenterol. 2007;13:5560-5570. (Pubitemid 350031475)
4. Yamamoto-Furusho JK. Genetic factors associated with the development of inflammatory bowel disease. World J Gastroenterol. 2007;13:5594-5597. (Pubitemid 350031479)
5. Arend WP. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J Clin Invest. 1991;88:1445-1451.
6. Tountas NA, Casini-Raggi V, Yang H, et al. Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology. 1999;117:806-813. (Pubitemid 29468222)
7. Arend WP, Guthridge CJ. Biological role of interleukin 1 receptor antagonist isoforms. Ann Rheum Dis. 2000;59(suppl):i60-i64.
8. Steinkasserer A, Spurr NK, Cox S, et al. The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci. Genomics. 1992;13:654-657.
9. Patterson D, Jones C, Hart I, et al. The human interleukin-1 receptor antagonist (IL1RN) gene is located in the chromosome 2q14 region. Genomics. 1993;15:173-176. (Pubitemid 23079586)
10. Nemetz A, Nosti-Escanilla MP, Molnar T, et al. IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease. Immunogenetics. 1999;49:527-531. (Pubitemid 29221785)
11. Celik Y, Dagli U, Kiliç MY, et al. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease. Scand J Gastroenterol. 2006;41:559-565.
12. Mittal RD, Bid HK, Ghoshal UC. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India. Scand J Gastroenterol. 2005;40:827-831. (Pubitemid 40978859)
13. Vijgen L, Van Gysel M, Rector A, et al. Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease. Genes Immun. 2002;3:400-406. (Pubitemid 41656538)
14. Craggs A, West S, Curtis A, et al. Absence of a genetic association between IL-1RN and IL-1B gene polymorphisms in ulcerative colitis and Crohn disease in multiple populations from northeast England. Scand J Gastroenterol. 2001;36:1173-1178. (Pubitemid 32917586)
15. Henriksen M, Jahnsen J, Lygren I, et al; IBSEN Study Group. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis. 2006;12:543-550.
16. Yamamoto-Furusho JK, Torijano-Carrera E. Intestinal protozoa infections among patients with ulcerative colitis: prevalence and inpact on clinical disease course. Digestion. 2010;82:18-23.
17. González-Treviño O, Yamamoto-Furusho JK, Cutiño-Moguel T, et al. HLA Study on two Mexican Mestizo families with autoimmune thyroid disease. Autoimmunity. 2002;35:265-269.
18. Miller S, Dykes D, Polesky H. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215-1220.
19. Mansfield JC, Holden H, Tarlow JK, et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology. 1994;106:637-642.
20. Danis VA, Millington M, Hyland VJ, et al. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-IRa) gene polymorphism. Clin Exp Immunol. 1995;99:303-310.
21. Mignone F, Gissi C, Liuni S, et al. Untranslated regions of mRNAs. Genome Biol. 2002;3:1-10.
22. Bashirullah A, Cooperstock RL, Lipshitz HD. Spatial and temporal control of RNA stability. Proc Natl Acad Sci U S A. 2001;98:7025-7028. (Pubitemid 32567897)
23. Corleto VD, Pagnini C, Margagnoni G, et al. IL-1beta-511 and IL-1RN*2 polymorphisms in inflammatory bowel disease: an Italian population study and meta-analysis of European studies. Dig Liver Dis. 2010;42:179-184.
24. Li KS, Wang BY, Liu SY, et al. The combination of polymorphisms within MCP-1 and IL-1beta associated with ulcerative colitis. Int J Immunogenet. 2009;36:135-129.
25. Iacoviello L, Di Castelnuovo A, Gattone M, et al; IGIGI Investigators. Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol. 2005;25:222-227.
26. van Minkelen R, Wettinger SB, de Visser MC, et al. Haplotypes of the interleukin-1 receptor antagonist gene, interleukin-1 receptor antagonist mRNA levels and the risk of myocardial infarction. Atherosclerosis. 2009;203:201-205.
27. Zee RY, Hennessey H, Michaud SE, et al. Genetic variants within the interleukin-1 gene cluster, and risk of incident myocardial infarction, and ischemic stroke: a nested case-control approach. Atherosclerosis. 2008;201:124-129.
28. Yamamoto-Furusho JK, Uscanga LF, Vargas-Alarcón G, et al. Polymorphisms in the promoter region of tumour necrosis factor alpha (TNF-α) and the HLA-DRB1 locus in Mexican Mestizo patients with ulcerative colitis. Immunol Letters. 2004;95:31-35. (Pubitemid 39119897)
29. Yamamoto-Furusho JK, Uscanga LF, Vargas-Alarcón G, et al. Clinical and genetic heterogeneity in Mexican patients with ulcerative colitis. Human Immunol. 2003;64:119-123. (Pubitemid 36109820)
30. Gelbmann CM, Rogler G, Gierend M, et al. Association of HLA-DR genotypes and IL-1ra gene polymorphism with treatment failure of budesonide and disease patterns in Crohn's disease. Eur J Gastroenterol Hepatol. 2001;13:1431-1437. (Pubitemid 33151495)
31. Yamamoto-Furusho JK, Rodríguez-Bores L, Granados J. HLA-DRB1 alleles are associated with the clinical course of disease and steroid dependence in Mexican patients with ulcerative colitis. Colorectal Dis. 2009; doi: 10.1111/j.1463-1318.2009.02025.x. published on line on Aug 5.
32. Yamamoto T, Saniabadi AR, Umegae S, et al. Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: cytokine profiles and endoscopic findings. Inflamm Bowel Dis. 2006;12:719-726. (Pubitemid 44253756)
33. Sakimura K, Omori T, Iwashita E, et al. Clinical response is associated with elevated plasma interleukin-1 receptor antagonist during selective granulocyte and monocyte apheresis in patients with ulcerative colitis. Dig Dis Sci. 2006;51:1525-1531. (Pubitemid 44379293)